IRIS
HEFFLER, Enrico Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.574
AS - Asia 7.550
EU - Europa 2.627
SA - Sud America 1.658
AF - Africa 413
OC - Oceania 49
Continente sconosciuto - Info sul continente non disponibili 10
AN - Antartide 1
Totale 22.882
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.320
SG - Singapore 4.701
BR - Brasile 1.370
CN - Cina 999
VN - Vietnam 751
DE - Germania 448
FI - Finlandia 407
IT - Italia 404
IE - Irlanda 318
NG - Nigeria 263
HK - Hong Kong 242
FR - Francia 212
IN - India 176
GB - Regno Unito 171
NL - Olanda 153
CA - Canada 131
AR - Argentina 114
MX - Messico 89
SE - Svezia 89
BD - Bangladesh 88
RU - Federazione Russa 78
TR - Turchia 75
ID - Indonesia 61
IQ - Iraq 59
ZA - Sudafrica 53
TW - Taiwan 50
EC - Ecuador 47
JP - Giappone 45
ES - Italia 44
KR - Corea 44
AU - Australia 42
BE - Belgio 42
CZ - Repubblica Ceca 41
PK - Pakistan 38
PL - Polonia 37
CO - Colombia 34
UA - Ucraina 33
VE - Venezuela 30
CH - Svizzera 28
IL - Israele 26
CL - Cile 24
MY - Malesia 23
AT - Austria 22
JO - Giordania 22
MA - Marocco 22
SA - Arabia Saudita 22
PY - Paraguay 17
UZ - Uzbekistan 16
EG - Egitto 15
RO - Romania 15
DZ - Algeria 13
AE - Emirati Arabi Uniti 12
AZ - Azerbaigian 12
KE - Kenya 12
PH - Filippine 12
NP - Nepal 11
LT - Lituania 10
PE - Perù 10
TN - Tunisia 10
UY - Uruguay 10
AL - Albania 9
IR - Iran 8
PT - Portogallo 8
TH - Thailandia 8
KZ - Kazakistan 7
NO - Norvegia 7
SN - Senegal 7
DK - Danimarca 6
ET - Etiopia 6
HR - Croazia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BA - Bosnia-Erzegovina 5
BG - Bulgaria 5
GR - Grecia 5
KG - Kirghizistan 5
LB - Libano 5
NZ - Nuova Zelanda 5
OM - Oman 5
PA - Panama 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
HU - Ungheria 4
JM - Giamaica 4
LV - Lettonia 4
MD - Moldavia 4
NI - Nicaragua 4
PS - Palestinian Territory 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
AM - Armenia 3
BH - Bahrain 3
CI - Costa d'Avorio 3
GM - Gambi 3
GT - Guatemala 3
SI - Slovenia 3
XK - ???statistics.table.value.countryCode.XK??? 3
CY - Cipro 2
EU - Europa 2
KH - Cambogia 2
KW - Kuwait 2
Totale 22.849
Salva come PNG Salva come JPEG
Città #
Singapore 1.961
Chandler 1.322
Wilmington 1.289
Dallas 799
The Dalles 732
Ashburn 662
San Mateo 482
San Jose 467
Shanghai 452
Ann Arbor 416
Helsinki 402
Dublin 296
Ho Chi Minh City 269
Benin City 259
Boardman 257
Lawrence 234
Princeton 234
Leawood 221
Hong Kong 209
New York 203
Beijing 201
Hanoi 166
São Paulo 126
Falkenstein 125
Fairfield 124
Paris 124
Woodbridge 107
Amsterdam 106
Los Angeles 97
Santa Clara 88
London 67
Toronto 67
Milan 61
Seattle 52
Munich 40
Orem 40
Rio de Janeiro 40
Council Bluffs 38
Belo Horizonte 36
Da Nang 36
Haiphong 36
San Diego 35
Redwood City 34
Brussels 31
Columbus 30
Kocaeli 30
Norwalk 30
Menlo Park 28
Naples 28
Pune 28
Warsaw 28
Phoenix 27
Curitiba 24
Frankfurt am Main 24
Tokyo 24
Johannesburg 23
Mexico City 23
Brasília 22
Campinas 22
Baghdad 21
Chennai 21
Monmouth Junction 21
Boston 20
Brno 20
Newark 20
Stockholm 20
Houston 19
Mumbai 19
Amman 18
Guayaquil 18
Jakarta 18
Montreal 18
Brooklyn 17
Porto Alegre 17
Salvador 17
Buffalo 16
Falls Church 15
San Francisco 15
Can Tho 14
Chicago 14
Dongguan 14
Hyderabad 14
Nuremberg 14
Goiânia 13
Guarulhos 13
Quito 13
Rome 13
Denver 12
Des Moines 12
Dhaka 12
Hillsboro 12
Hải Dương 12
Reston 12
Tashkent 12
Thái Bình 12
Asunción 11
Atlanta 11
Melbourne 11
Moscow 11
Philadelphia 11
Totale 14.057
Salva come PNG Salva come JPEG
Nome #
The 10th anniversary of the Junior Members and Affiliates of the European Academy of Allergy and Clinical Immunology. 753
Multi-strain Symbiotic Preparations as a Novel Adjuvant Approach to Allergic Rhinitis 370
Probiotics as a Novel Adjuvant Approach to Atopic Dermatitis 301
Olfactory impairment in Italian patients with chronic rhinosinusitis with nasal polyps: a patient-centered survey 190
NAPPREB study protocol: A pivotal clinical trial to investigate clinical efficacy and potential response biomarkers to Benralizumab treatment in chronic rhinosinusitis with nasal polyps 162
"Characteristics of patients admitted to emergency department for asthma attack: a real-LIFE study". 153
A critical appraisal on AIT in childhood asthma. 149
Very rapid improvement of extended nitric oxide parameters, associated with clinical and functional betterment, in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) treated with Dupilumab 132
Research needs in allergy: an EAACI position paper, in collaboration with EFA 132
Multiple Drug Allergy Due to Hypersensitivity to Polyethylene Glycols of Various Molecular Weights 129
Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry 126
Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients. 125
Macrogol hypersensitivity reactions during cleansing preparation for colon endoscopy. 124
Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model 119
Hypersensitivity to gelatin used as excipient for soft capsules of Ibuprofen 118
Allergic patients during the COVID-19 pandemic-Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey 117
Italian study on buckwheat allergy: prevalence and clinical features of buckwheat-sensitized patients in Italy 117
The accuracy of the HemoCue WBC DIFF in assessing blood eosinophils depends on the clinical setting and medical condition 116
An academic allergy unit during COVID-19 pandemic in Italy. 116
Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: an Italian Multicenter Study. 115
Allergy in severe asthma. 111
A prevalent exposure to male dog is a risk factor for exclusive allergic sensitization to Can f 5: An Italian Multicenter Study. 111
Acute urticaria presenting in the emergency room of a general hospital 111
Exhaled nitric oxide measurements: correction equation to compare hand-held device to stationary analyzer 110
Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper. 110
A Bloody Mess: An Unusual Case of Diffuse Alveolar Hemorrhage Because of Warfarin Overdose 110
Adherence issues related to sublingual immunotherapy as perceived by allergists. 107
Nasal nitric oxide concentration in suspected chronic rhinosinusitis 106
Allergy in internet 105
Acute asthma management during SARS-CoV2-pandemic 2020 102
Pertinence of requested allergy consultations for suspected food allergy/intolerance. A Junior Members working group of Italian Society of Allergy and Clinical Immunology (SIAIC) multicenter study. 101
Immunological mechanisms underlying chronic rhinosinusitis with nasal polyps 100
Incidence of food anaphylaxis in Piemonte region (Italy): data from registry of Center for Severe Allergic Reactions. 99
Aligning the Good Practice MASK With the Objectives of the European Innovation Partnership on Active and Healthy Ageing 98
Allergy to buckwheat: an emerging clinical problem. Clinical and laboratory analysis of 24 consecutive patients 97
The Severe Asthma Network in Italy: Findings and Perspectives 95
Evolving phenotypes to endotypes: is precision medicine achievable in asthma? 94
Level of exhaled nitric oxide during human anaphylaxis 94
Treatable traits in chronic rhinosinusitis with nasal polyps 94
Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis 94
Asthma from immune pathogenesis to precision medicine 93
Clinical presentation at the onset of COVID-19 and allergic rhinoconjunctivitis 93
Nasal cytology: Methodology with application to clinical practice and research. 92
Allergen immunotherapy and biologics in respiratory allergy: friends or foes? 91
Unexpected visitor: “hidden” food allergens 90
Reduction of oral corticosteroids in patients with severe eosinophilic asthma treated with Benralizumab: could it represent a marker of treatment efficacy? 89
Breath analysis in patients with end-stage renal disease: effect of haemodialysis 88
Exhaled nitric oxide in asthma. 88
Pharmacokinetics and pharmacodynamics of monoclonal antibodies for asthma treatment 88
Unexplained chronic cough and vitamin B-12 deficiency. 88
Exhaled nitric oxide as a clinical biomarker for choosing biologics for severe asthma treatment. 87
Anaphylaxis after a horse bite 87
Oxidative stress and airway inflammation after allergen challenge evaluated by exhaled breath condensate analysis 86
Anaphylaxis after eating italian pizza containing buckwheat as the hidden allergen 85
Strategies to reduce corticosteroid-related adverse events in asthma 85
One year of mepolizumab. Efficacy and safety in real-life in Italy 84
Pharmacoeconomic evaluation of oral corticosteroid adverse events in patients with severe asthma 84
Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma 84
Allergen immunotherapy: The growing role of observational and randomized trial "Real-World Evidence" 84
Alpha1-antitrypsin deficiency and asthma 84
Appropriateness in allergic respiratory diseases health care in Italy: definitions and organizational aspects 83
Prevalence of over-/misdiagnosis of asthma in patients referred to an allergy clinic. 82
Microarray Immunodiagnostics for Aeroallergens 82
Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets 80
Eosinophils Target Therapy for Severe Asthma: Critical Points 80
The Patient-Centered Decision System as per the 4Ps of Precision Medicine 80
Interleukin-5 in the Pathophysiology of Severe Asthma 80
Is air pollution affecting the disease activity in patients with systemic lupus erythematosus? State of the art and a systematic literature review. 79
Real-life studies of biologics used in asthma patients: key differences and similarities to trials 79
New drugs in early-stage clinical trials for allergic rhinitis 79
EAACI consensus statement for investigation of work-related asthma in non-specialized centres 79
Diagnostic classification of persistent rhinitis and its relationship to exhaled nitric oxide and asthma: a clinical study of a consecutive series of patients. 78
Gene Environment Interactions in Respiratory Diseases – Protocol, Standard Operative Procedures and Questionnaires 78
Escaping the trap of allergic rhinitis. 77
Determinants of exhaled nitric oxide in chronic rhinosinusitis 77
Bronchodilator response as a marker of poor asthma control 77
Long-lasting clinical, radiological and immunological remission of severe nasal polyposis by means of 'reboot' surgery. 77
Validation of the Italian version of the Test of Adherence to Inhalers (TAI) 77
Extended nitric oxide analysis in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma 77
Warning nonrespiratory symptoms in asthma: catastrophic abdominal involvement in a case of Churg-Strauss syndrome 76
Clinical manifestations, co-sensitizations, and immunoblotting profiles of buckwheat-allergic patients. 76
Minimal clinically important difference for asthma endpoints: an expert consensus report 76
Nasal nitric oxide in patients with inherited retinal dystrophies. 75
Advancing Precision Medicine in Asthma: Evolution of Treatment Outcomes 74
Exhaled nitric oxide's ability to predict methacholine challenge: a matter of definition 74
Kounis syndrome: Aspects on pathophysiology and management 74
Airways Type-2 Related Disorders: Multiorgan, Systemic or Syndemic Disease? 73
Do the current guidelines for asthma pharmacotherapy encourage over-treatment? 73
Alveolar concentration and bronchial output of exhaled nitric oxide in chronic rhinosinusitis 73
Validation and Qualification of Biomarkers and Their Translation Into Pathway-Specific Diagnostic Tests 73
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets 72
Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center 72
Exhaled breath condensate nitrates, but not nitrites or FENO, relate to asthma control. 72
When perennial rhinitis worsens: rhinolith mimicking severe allergic rhinitis. 72
Basophil activation test: a reliable biomarker for allergen immunotherapy? 72
Release of Type 2 Cytokines by Epithelial Cell of Nasal Polyps 72
Hypersensitivity reaction to human papillomavirus vaccine due to polysorbate 80. 72
Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study 72
Usefulness of exhaled nitric oxide (FeNO) measured by a portable analyzer to diagnose cough variant asthma in a clinical setting of chronic cough 72
The importance of being not significant: blood eosinophils and clinical responses do not correlate in severe asthma patients treated with Mepolizumab in real life. 72
Totale 10.501
Salva come PNG Salva come JPEG
Categoria #
all - tutte 138.059
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.059
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021595 0 0 0 0 0 0 0 0 0 311 43 241
2021/20221.422 62 37 51 298 22 30 52 190 117 110 380 73
2022/20233.681 550 149 348 416 354 295 26 290 657 297 234 65
2023/20242.110 183 242 437 66 114 184 90 136 63 60 176 359
2024/20254.141 128 105 78 106 156 385 229 392 643 925 467 527
2025/20269.127 1.378 623 992 1.086 317 388 2.606 669 554 514 0 0
Totale 23.137